103 results on '"Tomlins, Scott A."'
Search Results
2. Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need
3. Development and Validation of StrataNGS, a Multiplex PCR, Semiconductor Sequencing-Based Comprehensive Genomic Profiling Test
4. TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas
5. Invasive squamous cell carcinomas and precursor lesions on UV-exposed epithelia demonstrate concordant genomic complexity in driver genes
6. Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice
7. Development and Validation of a Deep-learning Model to Assist With Renal Cell Carcinoma Histopathologic Interpretation
8. Next-generation sequencing identifies recurrent copy number variations in invasive breast carcinomas from Ghana
9. A genomic survey of sarcomas on sun-exposed skin reveals distinctive candidate drivers and potentially targetable mutations
10. The role of the histone H3 variant CENPA in prostate cancer
11. Next-generation sequencing implicates oncogenic roles for p53 and JAK/STAT signaling in microcystic adnexal carcinomas
12. Circulating Tumor Cell–Based Molecular Classifier for Predicting Resistance to Abiraterone and Enzalutamide in Metastatic Castration-Resistant Prostate Cancer
13. Tubulocystic renal cell carcinoma: a distinct clinicopathologic entity with a characteristic genomic profile
14. TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer
15. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer
16. Association of tumor-infiltrating T-cell density with molecular subtype, racial ancestry and clinical outcomes in prostate cancer
17. Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays
18. Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen
19. Minimally Invasive Inguinal Lymphadenectomy in the Management of Penile Carcinoma
20. Comprehensive Determination of Prostate Tumor ETS Gene Status in Clinical Samples Using the CLIA Decipher Assay
21. Targeted next-generation sequencing of CIC-DUX4 soft tissue sarcomas demonstrates low mutational burden and recurrent chromosome 1p loss
22. Prognostic Value of Percent Gleason Grade 4 at Prostate Biopsy in Predicting Prostatectomy Pathology and Recurrence
23. Comprehensive genomic profiling of orbital and ocular adnexal lymphomas identifies frequent alterations in MYD88 and chromatin modifiers: new routes to targeted therapies
24. Porocarcinomas harbor recurrent HRAS-activating mutations and tumor suppressor inactivating mutations
25. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation
26. Clonal evaluation of prostate cancer foci in biopsies with discontinuous tumor involvement by dual ERG/SPINK1 immunohistochemistry
27. Mechanistic Support for Combined MET and AR Blockade in Castration-Resistant Prostate Cancer
28. Intra-tumor genetic heterogeneity in rectal cancer
29. The Molecular Taxonomy of Primary Prostate Cancer
30. DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis
31. Integrative Clinical Genomics of Advanced Prostate Cancer
32. Development and Validation of a Scalable Next-Generation Sequencing System for Assessing Relevant Somatic Variants in Solid Tumors
33. Reprint of: The prostate cancer genome: Perspectives and potential
34. Assessing Copy Number Alterations in Targeted, Amplicon-Based Next-Generation Sequencing Data
35. HRAS mutations are frequent in inverted urothelial neoplasms
36. Understanding the Relationship Between Tumor Size, Gland Size, and Disease Aggressiveness in Men With Prostate Cancer
37. Papillary renal cell carcinoma revisited: a comprehensive histomorphologic study with outcome correlations
38. Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization—a correlative study with urine PCA3 and TMPRSS2-ERG
39. Novel dual-color immunohistochemical methods for detecting ERG–PTEN and ERG–SPINK1 status in prostate carcinoma
40. Twenty-First Century Pathology Sign-Out
41. Role of Transcriptional Corepressor CtBP1 in Prostate Cancer Progression
42. Detection of Somatic Copy Number Alterations in Cancer Using Targeted Exome Capture Sequencing
43. Coordinated Regulation of Polycomb Group Complexes through microRNAs in Cancer
44. Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
45. Antibody-Based Detection of ERG Rearrangement-Positive Prostate Cancer
46. An Integrated Network of Androgen Receptor, Polycomb, and TMPRSS2-ERG Gene Fusions in Prostate Cancer Progression
47. Characterization of ETS gene aberrations in select histologic variants of prostate carcinoma
48. Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
49. Standardizing the definition of adverse pathology for lower risk men undergoing radical prostatectomy
50. Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.